ALVR106 in Treatment of High-Risk Patients with Respiratory Viral Infections After HSCT

Clinical Trial Grant

Duke Scholars

Principal Investigator Mitchell Eric Horwitz Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Allovir, Inc.

Start Date

May 27, 2021

End Date

June 14, 2026

Awarded By

Allovir, Inc.

Start Date

May 27, 2021

End Date

June 14, 2026